Please use this identifier to cite or link to this item:
|Title:||Caspase proteases mediate apoptosis induced by anticancer agent preactivated MC540 in human tumor cell lines||Authors:||Pervaiz, S.
|Issue Date:||1998||Citation:||Pervaiz, S., Hirpara, J.L., Clement, M.-V. (1998). Caspase proteases mediate apoptosis induced by anticancer agent preactivated MC540 in human tumor cell lines. Cancer Letters 128 (1) : 11-22. ScholarBank@NUS Repository. https://doi.org/10.1016/S0304-3835(98)00021-4||Abstract:||The molecular events involved in tumor cell death induced by novel photoproducts of merocyanine 540 (pMC540) are poorly understood. Using HL60 leukemia and M14 melanoma cell lines we investigated the role of the apoptotic pathway in pMC540-mediated cell death. Tumor cells exposed to pMC540 showed cell size shrinkage and an increase in the sub-diploid DNA content. A loss of membrane phospholipid asymmetry associated with apoptosis was induced by pMC540 in both tumor cell lines as evidenced by the externalization of phosphatidylserine. A dose-dependent increase in caspase-3 protease activity suppressed by the tetrapeptide inhibitor DEVD-CHO was observed in both cell lines. Western blot analysis of poly (ADP-ribose) polymerase, a caspase substrate, showed the classical cleavage pattern (116 to 89 kDa) associated with apoptosis in pMC540-treated cell lysates. Furthermore, caspase inhibition blocked the externalization of membrane PS, indicating that the loss of membrane phospholipid asymmetry is a downstream event of caspase activation. These findings demonstrate that tumor cell death induced by pMC540 is mediated by caspase proteases.||Source Title:||Cancer Letters||URI:||http://scholarbank.nus.edu.sg/handle/10635/29719||ISSN:||03043835||DOI:||10.1016/S0304-3835(98)00021-4|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 8, 2020
WEB OF SCIENCETM
checked on Jul 1, 2020
checked on Jun 30, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.